Mouse mammary tumor virus (MMTV) is a type B retrovirus that is transmitted through milk and causes mammary carcinomas in mice. The ultimate target tissue for MMTV is the mammary gland, where viral integration near cellular oncogenes results in mammary tumors. However, MMTV also utilizes the cells of the immune system in its journey from milk to the mammary gland of offspring that suckle on viremic mothers. A better understanding of how MMTV infects these different cell types and reaches its target tissue is dependent on identifying the cell surface receptor(s) that the virus uses to infect cells. Preliminary data are presented indicating that the applicant recently cloned the MMTV receptor (MTVR). The goal of the experiments described in this proposal is to characterize this cell surface receptor and to study its role in MMTV transmission and mammary gland infection. Detailed analysis of the gene structure, transcripts and of the encoded protein will allow the applicant to understand why MMTV only infects and transforms specific cell types. Moreover, the role of the receptor in virus transfer between different cell types will be studied. Targeted mutation of the receptor genes in tissue culture cells and in transgenic animals will be performed, to test if the gene is necessary and sufficient for MMTV infection of all cell types and to begin to determine its normal cellular function. The human equivalent of the MTVR gene will be cloned and used in """"""""domain swap"""""""" experiments to determine what sequences within the mouse MTVR are required for virus binding.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project (R01)
Project #
1R01CA073746-01
Application #
2011751
Study Section
Experimental Virology Study Section (EVR)
Project Start
1997-05-15
Project End
2002-01-31
Budget Start
1997-05-15
Budget End
1998-01-31
Support Year
1
Fiscal Year
1997
Total Cost
Indirect Cost
Name
University of Pennsylvania
Department
Microbiology/Immun/Virology
Type
Schools of Medicine
DUNS #
042250712
City
Philadelphia
State
PA
Country
United States
Zip Code
19104
Kim, Hyoung H; Grande, Shannon M; Monroe, John G et al. (2012) Mouse mammary tumor virus suppresses apoptosis of mammary epithelial cells through ITAM-mediated signaling. J Virol 86:13232-40
Okeoma, Chioma M; Huegel, Alyssa L; Lingappa, Jaisri et al. (2010) APOBEC3 proteins expressed in mammary epithelial cells are packaged into retroviruses and can restrict transmission of milk-borne virions. Cell Host Microbe 8:534-43
Wang, Enxiu; Obeng-Adjei, Nyamekye; Ying, Qihua et al. (2008) Mouse mammary tumor virus uses mouse but not human transferrin receptor 1 to reach a low pH compartment and infect cells. Virology 381:230-40
Ross, Susan R; Schmidt, John W; Katz, Elad et al. (2006) An immunoreceptor tyrosine activation motif in the mouse mammary tumor virus envelope protein plays a role in virus-induced mammary tumors. J Virol 80:9000-8
Wang, Enxiu; Albritton, Lorraine; Ross, Susan R (2006) Identification of the segments of the mouse transferrin receptor 1 required for mouse mammary tumor virus infection. J Biol Chem 281:10243-9
Goedert, J J; Rabkin, C S; Ross, S R (2006) Prevalence of serologic reactivity against four strains of mouse mammary tumour virus among US women with breast cancer. Br J Cancer 94:548-51
Katz, Elad; Lareef, Mohamed H; Rassa, John C et al. (2005) MMTV Env encodes an ITAM responsible for transformation of mammary epithelial cells in three-dimensional culture. J Exp Med 201:431-9
Burzyn, Dalia; Rassa, John C; Kim, David et al. (2004) Toll-like receptor 4-dependent activation of dendritic cells by a retrovirus. J Virol 78:576-84
Hein, Sibyll; Prassolov, Vladimir; Zhang, Yuanming et al. (2003) Sodium-dependent myo-inositol transporter 1 is a cellular receptor for Mus cervicolor M813 murine leukemia virus. J Virol 77:5926-32
Zhang, Yuanming; Rassa, John C; deObaldia, Maria Elena et al. (2003) Identification of the receptor binding domain of the mouse mammary tumor virus envelope protein. J Virol 77:10468-78

Showing the most recent 10 out of 14 publications